FDA 483 - GlaxoSmithKline dba Human Genome Sciences Inc - March 15, 2019
FDA 483 for GlaxoSmithKline dba Human Genome Sciences Inc on March 15, 2019. Product: drugs. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for GlaxoSmithKline dba Human Genome Sciences Inc on March 15, 2019. Product: drugs. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
March 15, 2019
Product Type
drugs
ID: d826d0ff-2abb-4e17-978e-118bec3fad2e
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox